Johnson & Johnson: 10-K Risk Factor Changes

2026 vs 2025  ·  SEC EDGAR  ·  2026-10-16
⚠ AI Risk Brief Interpretation layer — deterministic data below

Orthopaedics separation uncertainty and cybersecurity threats escalate J&J's risk profile significantly.

Direction ↑ More concerning
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

3
New Risks
0
Removed
6
Modified
14
Unchanged
🟢 New in Current Filing Disclosure change8/10

The planned separation of the Company's Orthopaedics business may not be completed on the terms or timeline currently contemplated, if at all, and may not achieve the expected results

🟢 New in Current Filing The costs to complete the planned separation will be significant. In addition, the Company may be unable to achieve some of the strategic and financial benefits that it expects to achieve from the planned separation of the Company's Orthopaedics business 🔒
🟢 New in Current Filing Following the planned separation, the price of shares of the Company's common stock may fluctuate significantly 🔒
🟡 Modified An information security incident, including a cybersecurity breach, could have a negative impact on the Company’s business or reputation. 🔒

And 5 more changes in the full comparison.

8 more changes in this filing

Full diff access, historical comparisons, and cross-company signal tracking.

Get Pro access Already a Pro subscriber? View full diff →